Watch Ticker

Tiziana Life Sciences Ltd. Common Shares

Go to Tiziana Life Sciences Ltd. Common Shares Website

$2.33

0.00 (0.00%)

Live

Previous Close

$2.33

Day Range

$0 - $0

Previous Day Range

$2.2014 - $2.46

Market Cap

$267.6 million USD

Day Vol.

Previous Day Vol.

346735

Currency

USD

Primary Exchange

Nasdaq

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Mul...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Tiziana Life Sciences to Present at the 37th Annual Roth Conference

Tiziana Life Sciences, a biotechnology company, announced that its CEO will present at the 37th Annual ROTH Conference. The company's lead development candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody, has shown promising results in an open-label expanded access program and is currently being studied in a Phase 2a trial for non-active secondary progressive multiple sclerosis.

Related tickers: TLSA.

Read Full Article

N/A - Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3

Tiziana Life Sciences announced positive results from preclinical studies using its nasal anti-CD3 monoclonal antibody in treating traumatic spinal cord injury. The treatment demonstrated notable improvements in motor function, highlighting its potential as a transformative therapeutic approach.

Related tickers: TLSA.

Read Full Article

Trending Tickers

Please sign in to view